Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RA-BioStop ultrasound biomarker study for withdrawal of biologic DMARDs in rheumatoid arthritis
2011-005204-15Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- May 2012
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab, etanercept, adalimumab, certolizumab pegol, golimumab in rheumatoid arthritis (RA), sponsored by Medical University of Graz. Started May 2012; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2011-005204-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005204-15.